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ABSTRACT
Background: Daily consumption of Concord grape juice (CGJ)
over 3–4 mo has been shown to improve memory function in adults
with mild cognitive impairment and reduce blood pressure in hy-
pertensive adults. These benefits likely result from the high concen-
tration of polyphenols in CGJ. Increased stress can impair cognitive
function and elevate blood pressure. Thus, we examined the poten-
tial beneficial effect of CGJ in individuals with somewhat stressful
and demanding lifestyles.
Objective: We sought to examine the effects of the daily consump-
tion of CGJ for 12 wk on cognitive function, driving performance,
and blood pressure in healthy, middle-aged working mothers.
Design: Twenty-five healthy mothers (aged 40–50 y) of preteen
children who were employed for $30 h/wk consumed 12 ounces
(355 mL) of either CGJ (containing 777 mg total polyphenols)
or an energy-, taste-, and appearance-matched placebo daily for
12 wk according to a randomized crossover design with a 4-wk
washout. Verbal and spatial memory, executive function, atten-
tion, blood pressure, and mood were assessed at baseline and
at 6 and 12 wk. Immediately after the cognitive battery, a sub-
sample of 17 women completed a driving performance assess-
ment at the University of Leeds Driving Simulator. The 25-min
driving task required participants to match the speed and di-
rection of a lead vehicle.
Results: Significant improvements in immediate spatial memory
and driving performance were observed after CGJ relative to pla-
cebo. There was evidence of an enduring effect of CGJ such that
participants who received CGJ in arm 1 maintained better perfor-
mance in the placebo arm.
Conclusions: Cognitive benefits associated with the long-term
consumption of flavonoid-rich grape juice are not exclusive to
adults with mild cognitive impairment. Moreover, these cogni-
tive benefits are apparent in complex everyday tasks such as
driving. Effects may persist beyond the cessation of flavonoid
consumption, and future studies should carefully consider the
length of washout within crossover designs. This trial was regis-
tered at clinicaltrials.gov as NCT01411631. Am J Clin Nutr
2016;103:775–83.
Keywords: cognitive function, driving, flavonoids, grape juice,
polyphenols, cognition, anthocyanins, memory
INTRODUCTION
Systematic reviews have suggested that the consumption of
polyphenol-rich foods and drinks such as grape juice, blueberries,
and cocoa are associated with cognitive benefits in humans (1).
Concord grape juice (CGJ)6 is a rich source of polyphenols,
particularly flavonoids such as proanthocyanidins and anthocy-
anins, which have been postulated to positively affect cognitive
function by a variety of mechanisms, including the inhibition of
neuroinflammation (2), and inducing neurogenesis and synaptic
plasticity (3). Improved verbal learning and reduced semantic
interference on memory tasks in older adults with mild cognitive
impairment were reported after consuming CGJ daily for 12 and
16 wk (4, 5). Evidence for underlying mechanisms comes from
blueberry supplementation studies in aged (18 mo old) rats, in
which the increased activation of cAMP response element
binding protein led to higher hippocampal concentrations of
brain-derived neurotrophic factor. An accompanying benefit to
spatial working memory was observed after 3–12 wk of sup-
plementation (6). Enhanced vascular physiology in the brain
such as improved cerebral blood flow has been observed in
humans after the consumption of cocoa flavonols (7, 8). It is
proposed that such effects are mediated by the enhanced endo-
thelial function and increased bioavailability of nitric oxide (9,
10). Increased activation in the right-middle prefrontal and right
superior parietal cortical regions with use of fMRI was observed
in adults with mild cognitive impairment after CGJ consumption
1 Supported by Welch Foods Inc. This is a free access article, distributed
under terms (http://www.nutrition.org/publications/guidelines-and-policies/
license/) that permit unrestricted noncommercial use, distribution, and re-
production in any medium, provided the original work is properly cited.
*Towhom correspondence should be addressed. E-mail: l.dye@leeds.ac.uk.
ReceivedMay 5, 2015. Accepted December 31, 2015.
First published online February 10, 2016; doi: 10.3945/ajcn.115.114553.
6 Abbreviations used: AICc, Aikake information criterion; CGJ, Concord
grape juice; EAT-26, Eating Attitudes Test 26; HFS, high-frequency compo-
nent of steering; PSS, Perceived Stress Scale; RVIP, rapid visual information
processing; SDLP, SD of lane position; STAI, State-Trait Anxiety Inventory;
STREV, steering reversal rate; TETtLC2, time-to-line crossing ,2 s; TtLc,
time-to-line crossing; VSLT, visual spatial learning test; VVLT, visual verbal
learning test.
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enhanced cerebral blood flow. Endothelial and nitric oxide
pathways are implicated in the beneficial effects on cardiovas-
cular outcomes induced by CGJ and other polyphenol-rich foods
and drinks (11, 12).
The allostatic load model describes how chronic stress, car-
diovascular disease, and associated risk factors can lead to
a cascade of physiological and psychological consequences, such
as cognitive impairment (13–15). Individuals experiencing ele-
vated levels of daily stress may therefore be particularly re-
sponsive to the benefits of consuming polyphenol-rich foods
and drinks such as CGJ, as supported by animal models (16). We
recruited a healthy cohort of working mothers with preteen
children who reported experiencing a psychologically de-
manding and potentially stressful lifestyle and thus might benefit
from long-term polyphenol consumption. Although it is impor-
tant to consider the effects on specific cognitive domains
reflecting particular neurological processes, the ecological
validity, i.e., the extent to which performance on a battery of
cognitive tests is related to everyday cognitive tasks, is also
important (17). Driving is a highly ecological behavior requiring
a multitude of complex processes encompassing all cognitive
domains. Psychologically stressed individuals are more vulner-
able to driving errors because of an overload of attentional re-
sources (18). It is therefore of interest to examine whether
dietary polyphenol-based interventions can affect performance
on everyday tasks such as driving, which can be assessed in
a controlled laboratory environment. This study examined per-
formance on several cognitive domains shown to be sensitive to
berry polyphenol consumption (1) in addition to longitudinal
and lateral tracking tasks within an immersive driving environ-
ment with use of a state-of-the-art driving simulator.
METHODS
Design
CGJ or a placebo was consumed daily for 12 wk according to
a double-blind, randomized crossover design. Previous data in-
dicate that consuming CGJ daily for 12 wk is a sufficient duration
for detecting cognitive benefits (4). Participants were assigned to
1 of 2 orders (CGJ then placebo or placebo then CGJ) according
to a counterbalanced randomization schedule prepared by an
independent statistician. Outcome variables were assessed at
baseline (before drink consumption) and at 6 and 12 wk (after
daily consumption). Each arm was separated by a 4-wk washout.
Treatment drinks
The 12-ounce (355-mL) daily servings of CGJ and placebo
were matched for energy (233 kcal), appearance, taste, volume
(355 mL), carbohydrate content (59.5 g), and all sugars (54 g).
The CGJ contained 777 mg total polyphenolics as a gallic acid
equivalent/355-mL daily serving (167 mg anthocyanins as
malvidin equivalent and 334 mg proanthocyanidins as catechin
equivalent). Vitamin C was not present in either CGJ or placebo.
Total polyphenol concentration was determined by the Folin-
Ciocalteu procedure (19). Anthocyanins were determined by
a spectrophotometric procedure (20). Proanthocyanidins were
determined by normal-phase HPLC after solid-phase extraction
of the juice with a Sephadex LH-20 (Sigma-Aldrich) (21, 22).
The daily dosage was selected after evaluating previous research
showing that a 12-ounce daily dose of CGJ containing 740 mg
total polyphenolics over 12 wk is sufficient to detect cognitive
benefits (4). Both drinks were analyzed and prepared by Welch
Foods Inc. and refrigerated at 1–58C until distributed to the
participants, who were instructed to keep the juice refrigerated.
To ensure double blinding, the CGJ and placebo were labeled
with a 3-letter code by Welch Foods. The code was revealed to
the experimenters upon completion of the analysis. Both drinks
underwent standard microbiological and safety testing by Welch
Foods. To examine the equivalence of taste, participants re-
sponded to how pleasant they found the drink on a 10-cm Likert
scale after consumption at each visit.
Participants
Twenty-five working mothers were recruited from Leeds,
United Kingdom and the surrounding area. The inclusion criteria
were as follows: aged 40–50 y, at least 1 child aged ,13 y, BMI
(in kg/m2) of 18–29, works $30 h/wk, adequate understanding
of verbal and written English, possession of a full driving license
for .5 y, and having driven .5000 miles in the past year. Ex-
clusion criteria were smoking, self-reported menopausal symp-
toms, working night shifts, pregnant or planning pregnancy in
the next 6 mo, consuming .3 portions of fruit and vegetables/d,
vegetarian, current or history of eating disorder [.20 on the
Eating Attitudes Test 26 (EAT-26) (23)], and any current illness
or disease. The following additional exclusion criteria were re-
quired for the driving performance subsample: epilepsy, claus-
trophobia, fear of heights, and severe motion sickness. All
eligible participants completed a screening test drive in the
driving simulator and were familiarized with the cognitive test
battery and other measures before randomization. This required
completing a full version of the cognitive battery. Twenty-five
participants started arm 1. Two participants withdrew after
completing the first arm (both completed the placebo arm),
neither of whom gave a reason for withdrawal. An additional 4
participants withdrew during the second arm (CGJ: n = 3; pla-
cebo: n = 1). Of these 4 withdrawals, 1 reported depression
(CGJ), and 3 reported they no longer wanted to drink the juice.
Therefore, 25 participants completed the first arm, and 19
completed both arms. Of the 25 initial recruits, 17 met the
driving simulator inclusion/exclusion criteria. Cognitive per-
formance was the primary outcome measure; therefore, partic-
ipants who failed the driving simulator screening were retained,
and data were collected for all other outcome measures. Of the
17 participants who passed the driving simulator screening, 1
was excluded for not complying with the driving task. Of the
remaining 16 participants, driving performance data for both
arms were available for 11 (because, as described previously, 5
participants withdrew during arm 2). Participant characteristics
at screening are shown in Table 1.
Cognitive function
The 45-min cognitive test battery comprised 7 tests admin-
istered in the following order: visual verbal learning test (VVLT)
immediate recall (verbal memory), visual spatial learning test
(VSLT) immediate recall (nonverbal spatial memory), rapid
visual information processing (RVIP) (executive function),
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Grooved Pegboard (psychomotor skill) (Lafayette Instrument
Co.), Tower of Hanoi (executive function), and VVLT and VSLT
delayed recall. Equivalent versions of each test were incorporated
in a counterbalanced order across the 6 cognitive test sessions,
and the order in which the tests occurred within the cognitive test
battery remained constant across all administrations.
The VVLT is a visual analog of the Rey Auditory-Verbal
Learning Test (24). Three trials of 16 words (list A) were presented
in a random sequence on a computer screen at the rate of 1 word
every 2 s. At the end of each trial, participants were instructed to
verbally recall asmany of thewords as possible in a free-recall task
over 1 min (trials A1–A3). Trial A3 was followed by a pre-
sentation of a 16-word interference list (list B) and a subsequent
free recall of these words over 1 min (trial B1). A 1-min free
recall of list A without presentation immediately succeeded this
task (trial A4). Outcome variables were the mean number of
words recalled over trials A1–A3, retroactive interference (A3
and A4), and proactive interference (A1–B1). Delayed memory
was assessed 30 min after the initial presentation of the test.
The VSLT (25) is a test of visuospatial memory and learning. The
original version of the test was designed as an assessment of de-
mentia and involves 5 trials. However, to avoid ceiling effects in this
sample without dementia only, 3 trials were administered. At each
identical trial, participants were given 10 s to observe the image and
location of 7 abstract patterns placed on 53 4 grid. The task was to
correctly choose the 7 target patterns from a choice of 15 and place
them on the correct locations on the grid. The outcome variable was
the number of correct targets placed in the correct location per trial
(maximum of 7). Delayed VSLT performance was assessed 30 min
after the test was initially presented.
The RVIP involved a presentation of a series of single digits at
a rate of 600 ms with a 600-ms interstimulus interval. The task
lasted for 6 min with 100 stimuli/1-min block and 5 odd and 5
even targets within each block. Target sequences were 3 consec-
utively presented odd or even numbers that required participants to
press the spacebar as quickly as possible. Outcome variables were
the number of correctly identified sequences, the number of false-
positive responses, and reaction time for correct responses.
The Grooved Pegboard (26) assesses manual dexterity and is
a test of psychomotor skill. The apparatus consists of a board with
25 holes and 35 identical pegs. The pegs have a groove down
one side. Participants were asked to fill the holes with pegs in
a specified order as quickly as possible and completed the task
with their dominant hand followed by their nondominant hand.
The outcome variable was completion time to fill the board with
pegs (averaged across both hands).
The Tower of Hanoi (27) is a test of planning ability that is
considered an exemplar measure of executive function. A
computerized version was administered that consisted of a visual
representation of 3 rods on which 4 discs of different size and
color were placed. The target formation of discs on the rods was
at the top of the screen, and the starting formation was at the
bottom. The aim of the task was to rearrange the discs on the
starting formation rods to match the target formation in the fewest
possible moves. There was only 1 correct sequence of moves for
each trial. This was the fewest number of moves required to
match the target formation. If the participant deviated from the
correct sequence, the screen refreshed to the original starting
formation. There was one rule: a disc could not be placed on
a disc that was larger than itself; such moves were not recorded as
errors because the program would not allow it. At the outset, the
screen informed the participant of the number of moves required
to complete a trial. There were 10 trials/test administration that
consisted of 2 trials for each of the 5 levels of 4, 5, 6, 7, and 8
moves. Level 4 trials consisted of a sequence of 4 blocks, level 5
consisted of a sequence of 5 blocks, and so on. There were 2
outcome variables: number of errors made and completion time.
Blood pressure and subjective mood
Resting systolic and diastolic blood pressure were measured
with an Omron M7 ambulatory blood pressure monitor.
TABLE 1
Participant characteristics at baseline1
All participants
Participants undertaking the driving
performance task
ITT2 (n = 25) Completed (n = 19) ITT2 (n = 16) Completed (n = 10)
Age, y 43.2 6 0.6 42.8 6 0.7 42.6 6 0.7 42.5 6 0.9
Weight, kg 67.5 6 1.9 68.4 6 2.3 68.8 6 2.5 72.2 6 3.8
Height, m 1.7 6 0.01 1.7 6 0.02 1.7 6 0.02 1.7 6 0.02
BMI, kg/m2 24.6 6 0.5 24.4 6 0.5 24.8 6 0.6 25.0 6 0.7
BP, mm Hg
Systolic 127.7 6 2.1 127.9 6 2.8 129.4 6 2.6 127.7 6 2.9
Diastolic 82.6 6 2.7 82.6 6 3.5 86.2 6 3.5 82.6 6 3.6
NART3 37.4 6 1.6 38.6 6 1.7 35.7 6 2.2 37.4 6 3.1
Stress (PSS) 14.9 6 1.0 15.3 6 1.2 14.1 6 1.3 15.0 6 1.8
Cook-Medley Hostility Scale 14.9 6 1.5 13.8 6 1.8 15.3 6 2.0 16.4 6 2.9
Trait anxiety (STAIY2) 41.8 6 1.8 41.5 6 2.3 41.6 6 2.4 42 6 3.5
Eating behavior (EAT-26) 5.1 6 1.1 5.6 6 1.4 5.2 6 1.5 5.3 6 2.3
Preteen children, n 1.6 6 0.2 1.6 6 0.2 1.5 6 0.2 1.5 6 0.2
1Values are means 6 SEs. BP, blood pressure; EAT-26, Eating Attitudes Test 26; ITT, intention to treat; NART,
National Adult Reading Test; PSS, Perceived Stress Scale; STAIY2, State-Trait Anxiety Inventory Y2.
2This includes participants who withdrew during arm two.
3Maximum possible score of 50.
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Measurements were taken after participants rested their left upper
arm for 15 min, and the mean of 3 consecutive measurements was
calculated. Subjective mood was assessed with use of pen-and-
paper 100-mm visual analog scales with questions relating to
hunger, fullness, contentedness, irritability, sleepiness, mental
alertness, ability to concentrate, and energy with anchors for
each: “not at all” and “very.” Subjective stress was assessed with
the Perceived Stress Scale (PSS), and anxiety was assessed with
use of the short State-Trait Anxiety Inventory (STAI) 6-item
form MSTAIY6 (28, 29).
Driving performance
A 25-min virtual driving scenario of car following and lane
keeping was choreographed at the University of Leeds Advanced
Driving Simulator. The high-fidelity simulator consists of a
Jaguar S-type vehicle, a 4-m-diameter spherical projection dome
that houses an 11-channel display system covering a forward field
of view of 2708 and large amplitude, and an 8 degree-of-freedom
electrical motion system with 5 m of effective travel in surge
and sway. Driving performance was assessed by 2 tasks: lon-
gitudinal and lateral. The longitudinal and lateral tasks were
performed concurrently.
The longitudinal task required participants to follow a lead
vehicle at a safe and constant distance. The lead vehicle adjusted
its speed in a smooth fashion matching a 60-s period sine wave
with a maximum speed of 60 mph (w97 km/h) and minimum
speed of 40 mph (w64 km/h) until 5 cycles of the sine wave
were completed (a driving distance of w7 km). The drive
consisted of sections of straight and curved road. The curved
sections were alternate bends to the left and right with a radius
of 750 m and a length of 252 m. There were 3 independent
variables for the longitudinal task: coherence, phase shift, and
modulus (30). Coherence, a measure of correlation of the 2
speed cycles, indicates the accuracy of the participant’s speed
adjustments to meet the main longitudinal tracking task re-
quirement to maintain a consistent following distance. Co-
herence can range from 0 (no coherence between the 2 cycles) to
1 (perfect coherence). Phase shift measures the delay between
the change in the lead vehicle’s speed and the subsequent re-
sponse (akin to a delay in response). Modulus is an amplification
factor between the 2 signals, expressed as the amplitude gain; if
the participant overreacts to the lead vehicle’s speed changes,
the modulus will be larger than 1. Data were analyzed for the
final four of five 5-min sine wave cycles; the first cycle allowed
the participant time to settle into the task.
The lateral task required participants to maintain a constant
position in the driving lane. There were 4 outcome measures for
the lateral task: SD of lane position (SDLP), time-to-line crossing
(TtLC), steering reversal rate (STREV), and high-frequency
component of steering (HFS). The SDLP measured the variation
in lane position. TtLC was defined as the time to cross either lane
boundary with any of the wheels of the vehicle. Therefore, as
the vehicle approached the edge of the road, TtLC decreased. A
TtLC ,2 s was the threshold for close proximity to exiting the
lane boundary (31). A TtLC ,2 s is termed TETtLC2. The total
time of exposure during which TETtLC2 occurred was mea-
sured. Therefore, TETtLC2 defined the duration for which the
participant was driving in close proximity to the lane boundary.
STREV was the number of changes in steering wheel direction/min
(an angle of 18 is required to qualify as a reversal). A higher
STREV indicated higher difficulty in achieving accurate track-
ing. HFS reflected the number of steering corrections. Increased
corrections indicated erratic, reactive driving as opposed to
having a strong awareness of the road ahead, which is associated
with predictive steering and fewer corrections (32).
Procedure
Inclusion and exclusion criteria were checked at a screening
session that took place at the University of Leeds Human Ap-
petite Research Unit (as did all test days and procedures, not-
withstanding the driving simulator procedures, which took place
at the University of Leeds Advanced Driving Simulator).
Screening included a recruitment information questionnaire
(assessing general health), a measure of eating behavior (EAT-
26), the National Adult Reading Test (33), baseline PSS,
a measure of hostility (Cook-Medley Hostility Scale) (34), and
a measure of baseline trait anxiety (STAIY2) (29). Height,
weight, and blood pressure were measured, and familiarization
versions of the cognitive battery and driving performance task
were completed. Participants were informed that consumption of
the following polyphenol-rich drinks were not permitted for the
duration of the study, including the 4-wk washout: red wine,
grape juice (notwithstanding the treatment drink), or any dark
fruit juices. A minimum of 1 wk separated the screening visit and
test day 1. The day before each test day, participants refrained
from exercise and alcohol consumption after 1700 and were told
to consume an evening meal of their choice before 2100. The
meal was standardized across all test days (within participants) to
control for the cognitive effects of the second meal (35). Par-
ticipants fasted (except for water) from 2100. All test days
commenced between 0730 and 1000. Data were collected in the
following order: weight, mood 1 (visual analog scale), stress
(PSS), anxiety (MSTAIY6), and blood pressure. The treatment
drink was then consumed within 15 min followed by mood 2 and
the commencement of the cognitive battery. Mood 3 was assessed
upon completion of the cognitive battery, and participants were
escorted to the Institute for Transport Studies to commence the
driving performance task. Immediately before and after the
driving task, moods 4 and 5 were assessed. The total time for
the test day was approximately 2 h. To monitor compliance,
participants were required to return bottle tops from the con-
sumed drinks to the Human Appetite Research Unit on a weekly
basis and to complete a daily drink diary detailing the time of
consumption. Compliance was high; 22 participants reported
100% compliance, and all participants except 1 exceeded 90%
compliance (at least 75 d recorded). The lowest compliance was
76% (64 of 84 d recorded). Participants received a £160 hono-
rarium upon completion of the study or pro rata for withdrawals.
The University of Leeds School of Psychology Research Ethics
Committee reviewed the procedures and awarded a favorable
opinion for conduct. Recruitment commenced in January 2011
and ended in June 2012.
Statistical analysis
An independent statistician performed an intention-to-treat
analysis that included data for all participants who completed the
first arm (n = 25 for cognitive performance and n = 16 for
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driving performance). Within-subject ANCOVAs were per-
formed to examine the effects of condition (CGJ/placebo) and
visit [day 1 (baseline) and 6 and 12 wk] nested within the study
phase (arm 1/arm 2) on all outcome variables. Covariates were
age, IQ (National Adult Reading Test), subjective stress (PSS),
psychological hostility (Cook-Medley Hostility Scale), anxiety
(STAIY2), and eating behavior (EAT-26), all of which were
assessed during screening (see Procedure section).
All main effects and their interactions were requested in the
first model, and all covariates were included. Nonsignificant
interactions with covariates were removed first, and the analysis
was rerun. Nonsignificant covariates and higher-order in-
teractions of fixed factors were then removed. The resulting
model was compared with the previous model with use of the
McQuarrie and Tsai Aikake information criterion (AICc) (36).
The AICc gives an indication of the amount of remaining un-
explained variance after the model has been fitted, in which
a smaller AICc value indicates a better model. If an improvement
in model fit was found, other nonsignificant effects were re-
moved, and again the AICc was used to evaluate the model fit.
Models were chosen on the basis of best fit, and interaction terms
that improved the fit were retained. The reported ANCOVAs are
the best fit (i.e., lowest AICc) models adjusted for significant
covariates. Tukey-Kramer post hoc tests were employed to follow
up significant main effects or interactions, and the P values re-
ported are adjusted for multiple comparisons. Analyses were
performed with SAS version 9.3 (SAS Institute). All residuals
were screened, and outliers were removed.
RESULTS
Drink characteristics
The ANCOVA for pleasantness data showed no significant main
effects or interactions, indicating equivalence of taste. Upon
completion of both arms, 12 of 19 (63%) participants identified
CGJ as the active drink, which was not significantly different to
chance according to a 1-sample t test (t = 1.16; df = 18; P = 0.26).
Cognitive performance
Verbal recall
VVLT immediate recall averaged over the first 3 trials (A1–
A3) showed a significant condition 3 study phase interaction
[F(1, 20) = 4.61; P , 0.05]. As shown in Figure 1, post hoc
tests revealed that this interaction was specific to the placebo
condition, whereby recall was better when the placebo was
consumed in arm 2 relative to arm 1 (P , 0.05). This indicates
an initial benefit of the CGJ in arm 1 that endured until arm 2
when the placebo was consumed. No significant effects were
observed for retroactive, proactive interference, or delayed
VVLT recall (Table 2).
Spatial recall
VSLT immediate recall showed a significant main effect of
condition [F(1, 22) = 5.58; P , 0.05] such that recall (total over
3 trials) was higher after CGJ (mean: 12.72 items; SE: 0.39)
relative to placebo (mean: 12.57 items; SE: 0.36). Immediate
and delayed VSLT recall were significantly higher in arm 2
relative to arm 1, as indicated by a main effect of study phase
[immediate F(1, 21) = 12.8, P , 0.01; delayed F(1, 17) = 5.24,
P , 0.05].
Psychomotor skill
Completion time for the Grooved Pegboard showed a significant
condition 3 study phase interaction [F(1, 21) = 9.61; P , 0.01].
Post hoc tests revealed that the completion time in arm 1 was
significantly faster for the placebo (mean: 60.4 s; SE: 1.9 s) rel-
ative to CGJ (mean: 63.2 s; SE: 2.3 s) (P , 0.05), whereas no
difference was observed between the 2 drink conditions in arm 2.
Executive function
TOH completion time showed a significant condition 3 study
phase interaction [F(1, 21) = 14.12; P , 0.01]. As shown in
Figure 2, post hoc tests revealed that the completion time was
significantly faster for the CGJ relative to the placebo in arm 1
(P, 0.01), whereas this difference was not significant in arm 2. A
main effect of study phase was observed for the number of errors
[F(1, 21) = 5.27; P , 0.05] such that fewer errors were made in
arm 2 (mean: 3.6 errors; SE: 0.6) relative to arm 1 (mean: 6 er-
rors; SE: 1.1). No significant effects were observed for reaction
time, correctly identified targets, or false positives on the RVIP
(Table 2).
Driving performance
Longitudinal tracking task (car following)
Analysis of coherence revealed that the main effect of con-
dition was significant [F(1, 11) = 4.64; P = 0.05] such that car
following was more accurate during CGJ (mean correlation:
0.97; SE: 0.01) relative to placebo (mean correlation: 0.96;
SE: 0.01). Similarly, the main effect of condition approached
significance for phase-shift analysis [F(1, 11) = 4.26; P = 0.06]
such that CGJ was associated with a quicker driver response to
changes in the lead vehicle speed (CGJ mean: 3.54 s; SE: 0.54)
(placebo mean: 4.13 s; SE: 0.64). Finally, an analysis of mod-
ulus revealed a main effect of study phase [F(1, 10) = 6.67; P ,
0.05] such that performance was better (less overshoot) in arm 1
FIGURE 1 Immediate verbal recall (VVLT) averaged across trials A1–
A3 for each condition and study phase (means 6 SEs). The condition 3
study phase interaction for immediate verbal recall was significant [F(1, 22) =
5.58; P, 0.05]. Post hoc tests revealed that recall was better when the placebo
was consumed during arm 2 than during arm 1 (P , 0.05), indicating an
enduring effect of CGJ after the cessation of treatment. Placebo arm 1, n = 15;
CGJ arm 1, n = 14; placebo arm 2, n = 10; and CGJ arm 2, n = 9. CGJ,
Concord grape juice; VVLT, visual verbal learning test.
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(mean amplitude gain: 1.1; SE: 0.03) relative to arm 2 (mean
amplitude gain: 1.14; SE: 0.03).
Lateral tracking
A significant condition 3 study phase interaction was ob-
served for steering reversals [F(1, 10) = 16.73; P , 0.01] such
that during arm 1 steering control was more stable (fewer
steering reversals) for the CGJ condition, whereas steering
control during arm 2 was more stable for the placebo condition
(although post hoc tests did not reach significance; see Figure
3). No significant effects were observed for time-to-line crossing
(TETtLC2), lane position (SDLP), or the high-frequency com-
ponent of steering (HFS).
Subjective outcomes and blood pressure
Contentedness was significantly higher in arm 1 (mean: 64;
SE: 2.6) relative to arm 2 (mean: 60; SE: 2.5) as indicated by
a main effect of study phase [F(1, 21) = 5.35; P , 0.05].
Alertness and concentration were significantly higher for par-
ticipants who consumed CGJ in arm 1 (mean: 58 and 60 and SE:
3.6 and 3.7, respectively) relative to participants who consumed
TABLE 2
Scores for each cognitive test outcome, driving performance, and blood pressure at each test visit by condition1
Outcome
Placebo baseline
(n = 25)
Placebo week 6
(n = 24)
Placebo week 12
(n = 24)
CGJ baseline
(n = 23)
CGJ week 6
(n = 23)
CGJ week 12
(n = 20)
Significance and
effect observed
VVLT
Immediate recall2 33.8 6 1.1 34.8 6 1.3 35.4 6 1.3 34 6 1.3 36.2 6 1.2 36.2 6 1.6 Condition 3 study phase
Retroactive interference,3 % 19.9 6 3.1 13.6 6 2.5 15.9 6 4.7 12.6 6 2.9 11.6 6 2.3 15.8 6 6.0 —
Proactive interference,4 % 8.7 6 7.6 2.6 6 5.4 13.3 6 5.0 3.9 6 6.9 16.6 6 5.9 18.2 6 5.8 —
Delayed recall5 10.6 6 0.5 11.6 6 0.5 11.6 6 0.6 11.3 6 0.6 11.9 6 0.5 11.8 6 0.7 —
VSLT
Immediate recall6 12.4 61.2 12.4 6 1.0 13 6 1.1 11.3 6 1.1 12.2 6 1.3 14.1 6 1.2 Condition
Delayed recall7 4.6 6 0.4 5.1 6 0.4 4.7 6 0.5 4.7 6 0.4 5 6 0.5 5.5 6 0.4 Study phase
RVIP
Correct8 27.5 6 2.2 29.4 6 2.7 29 6 2.4 27.6 6 2.6 29.3 6 2.4 29.9 6 2.8 —
False positives 7.3 6 1.2 6.3 6 1.6 7.3 6 1.4 8.5 6 1.6 7.5 6 1.2 6.2 6 1.0 —
Reaction time, ms 458 6 12 457 6 18 452 6 14 454 6 16 459 6 13 461 6 16 —
Grooved Pegboard
completion time, s
62.6 6 2.3 60 6 2.1 60.6 6 2.0 61.2 6 2.5 61 6 2.1 59.3 6 2.1 Condition 3 study phase
TOH
Errors 5.6 6 1.4 5.1 6 1.1 4.5 6 1.0 4.4 6 0.7 5.5 6 1.0 4.1 6 0.6 Study phase
Completion time, s 246 6 22 240 6 17 213 6 11 224 6 11 240 6 25 210 6 11 Condition 3 study phase
Driving
Coherence9 0.97 6 0.009 0.95 6 0.011 0.95 6 0.008 0.97 6 0.009 0.97 6 0.016 0.97 6 0.013 Condition
Phase shift,10 s 4.0 6 0.5 4.5 6 0.8 3.9 6 0.6 3.7 6 0.7 3.6 6 0.4 3.3 6 0.5 Condition
Modulus11 1.13 6 0.04 1.09 6 0.05 1.09 6 0.04 1.1 6 0.03 1.13 6 0.02 1.14 6 0.02 Study phase
Lane position, SD 0.19 6 0.01 0.18 6 0.009 0.18 6 0.01 0.18 6 0.011 0.19 6 0.014 0.18 6 0.012 —
Exposure to lane
departure,12 %
30.5 6 1.1 32.6 6 1.7 31.4 6 1.1 30.7 6 1.0 31.3 6 1.3 31.1 6 1.5 —
Steering reversals/min13 26.5 6 2.8 24.9 6 1.9 25.4 6 2.4 26.0 6 2.2 23.8 6 1.8 26.4 6 2.5 Condition 3 study phase
High-frequency steering14 0.25 6 0.01 0.25 6 0.01 0.25 6 0.012 0.25 6 0.012 0.25 6 0.009 0.24 6 0.008 —
BP, mm Hg
Systolic 122 6 2.2 117 6 3.3 120 6 3.2 120 6 2.2 124 6 3.0 119 6 3.2 —
Diastolic 77 6 1.7 78 6 2.8 79 6 3.0 81 6 1.9 82 6 2.9 76 6 2.7 —
1Values are means 6 SEs unless otherwise indicated. P , 0.05 for all significance and effects observed (except for phase shift, which was P = 0.06). BP,
blood pressure; CGJ, Concord grape juice; RVIP, rapid visual information processing; TOH, Tower of Hanoi; VSLT, visual spatial learning test; VVLT, visual
verbal learning test.
2Sum of A1–A3.
3Number of words recalled during trial A3 2 words recalled during A4 as a percentage of the number of words recalled during A3.
4Number of words recalled during trial A1 2 words recalled during B1 as a percentage of the number of words recalled during A1.
5Maximum possible score of 16.
6Sum of 3 trials.
7Maximum possible score of 7.
8Maximum possible score of 60.
9Coherence is a correlation between the speed cycle of the participant and the lead vehicle ranging from 0 (no coherence between the 2 cycles) to 1
(perfect coherence).
10Phase shift measures the delay between the change in the lead vehicle’s speed and the subsequent response by the participant. A lower score indicates
better performance.
11If the participant overreacts to the lead vehicle’s speed changes, the modulus will be .1.
12Exposure to imminent lane departure (also known as time-to-line crossing).
13Driving steering reversals (number of changes in steering wheel direction per minute).
14Driving high-frequency steering is a proportion of high-frequency steering over all steering activity expressed in the frequency domain.
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CGJ in arm 2 (mean: 53 and 56 and SE: 3.4 and 3.3, re-
spectively; both P , 0.05), as indicated by significant condi-
tion 3 study phase interactions [F(1, 21) = 19.45; P , 0.001
and F(1, 21) = 24.98; P , 0.0001, respectively]. A significant
condition 3 study phase interaction was also observed for stress
ratings [F(1, 21) = 4.86; P , 0.05]; however, post hoc tests
failed to reach significance. There were no other significant ef-
fects of interest for the subjective mood outcomes or either di-
astolic or systolic blood pressure (Table 2).
DISCUSSION
CGJ was associated with better immediate spatial memory and
2 aspects of driving performance in this sample of healthy
working mothers (aged 40–50 y) of preteen children relative to
a placebo. Previous interventions that demonstrated the benefits
of CGJ have been performed exclusively in older adults with
mild cognitive impairment (4, 5); thus, this is the first study to
our knowledge to demonstrate cognitive benefits after CGJ in
healthy middle-aged adults. Combined with another recent study
that showed that executive function and memory improvements
after the consumption of flavanone-rich orange juice (37), these
results indicate that cognitive benefits achieved from regular
daily flavonoid consumption are not exclusive to adults ex-
hibiting cognitive decline or neurodegenerative disease. More-
over, long-term consumption of CGJ was associated with
a reduced phase shift in car following, which was comparable to
a quicker reaction time to unfolding traffic events. This was
evidenced by increased steering accuracy in combination with
a faster response time to changes in lead vehicle behavior during
car following. The observed effects would account for a re-
duction in stopping distance ofw11 m at the speeds driven (40–
60 mph; w64–97 km/h), which is an important safety benefit.
Thus, the cognitive effects of long-term CGJ consumption
translate into meaningful outcomes on everyday tasks.
The observed subtle benefit for spatial memory is consistent
with the literature on rodents (6, 38) and several other polyphenol
interventions in humans. It has been proposed that memory
function is particularly susceptible to potential mechanisms that
underlie the association between flavonoids and cognitive ben-
efits (3), possibly because the hippocampus is a region where
flavonoids and their metabolites seem capable of exerting their
actions (6, 38). In support of this proposal, improved performance
of a spatial recognition task and increased activation with use of
fMRI was seen in the dentate gyrus (a subregion of the hippo-
campus) in healthy older adults after consuming flavonol-rich
cocoa for 3 mo (7).
The consistent interaction between drink condition and study
phase in this study over a number of cognitive outcomes suggests
enduring effects of CGJ after the cessation of consumption.
Specifically, benefits for verbal recall, executive function, and
lateral tracking associated with CGJ consumption in arm 1
persisted into the second arm when the placebo was consumed.
Similar enduring effects were recently reported after 8 wk of
consumption of flavanone-rich orange juice after a 4-wk washout
on tests of executive function and memory (37). These enduring
effects may signify that polyphenols cause relatively stable
physiologic effects that do not dissipate rapidly after withdrawal
from the diet. This has implications for determining a suitable
washout period between treatments; 4 wk may not be sufficient in
flavonoid interventions. It is also noteworthy that persistent main
effects of study phase revealed performance was significantly
better during the second arm regardless of the drink consumed
(e.g., immediate and delayed spatial memory, executive function).
This indicates practice effects, whereby participants improved
over time. Given that cognitive benefits in healthy populations are
likely to be small (17), it is crucial that potential practice effects
are considered by including study phase and drink order within
statistical models examining cognitive effects of flavonoid in-
terventions. This study phase effect was not exclusive to objective
cognitive outcomes; higher ratings of alertness and concentration
were reported during the first arm relative to the second arm
(albeit only for the CGJ condition). It is perhaps not surprising
that the alertness and conscientiousness of participants may
decline over the course of a 28-wk trial, and it is entirely pos-
sible that these subjective effects have an impact on cognitive
performance (39). This possibility further emphasizes the
FIGURE 2 Tower of Hanoi completion time (s) for each condition and
study phase (means 6 SEs). The condition 3 study phase interaction was
significant [F(1, 21) = 14.12; P , 0.01]. Post hoc tests revealed that com-
pletion time was significantly faster for the CGJ (n = 14) relative to the
placebo for arm 1 (n = 15; P , 0.01). This difference was not significant
for arm 2. Placebo arm 1, n = 15; CGJ arm 1, n = 14; placebo arm 2, n = 10;
and CGJ arm 2, n = 9. CGJ, Concord grape juice.
FIGURE 3 Steering reversals on the driving performance task for each
condition and study phase (means 6 SEs). The condition 3 study phase
interaction was significant for steering reversals [F(1, 10) = 16.73; P, 0.01)
such that during arm 1 performance was better (fewer reversals) for the CGJ
condition (n = 8), whereas performance during arm 2 was better for the
placebo condition (n = 5). However, post hoc tests did not reach significance.
Placebo arm 1, n = 8; CGJ arm 1, n = 8; placebo arm 2, n = 5; and CGJ arm
2, n = 5. CGJ, Concord grape juice.
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importance of considering order effects in long-term in-
terventions. Previous studies that reported strong effects of CGJ
on immediate verbal memory (4) and spatial recognition (5)
adopted a parallel group design in which order effects were
avoided.
The data from this study show that grape flavonoids may
improve performance on everyday tasks; safer driving behavior
was observed after the CGJ relative to the placebo, as indicated
by characteristics such as a faster response to the lead vehicle.
The potential for flavonoid-rich diets to have a small but im-
portant impact on cognitive tasks such as driving should not be
overlooked, and future research should consider effects on other
ecologically valid everyday tasks throughout the lifespan. Acute
benefits of flavonoid consumption for the peripheral vascular
system in the immediate postprandial period arewell documented
(10). Several studies have shown improvements in endothelial
function in patients with heart disease after grape juice supple-
mentation (40, 41); however, our data did not show any long-term
effects of CGJ on blood pressure. This could be a function of the
population; the sample of healthy middle-aged women did not
have high blood pressure at the outset; therefore, the potential for
a relatively short dietary intervention to have a meaningful
impact is limited.
It is important to point out that during this 28-wk trial par-
ticipants did not abstain from all dietary sources of anthocyanins
and other polyphenols. The specific restrictions included red
wine, dark fruit juice, and any other grape juice. It is possible that
the participants consumed other sources of polyphenols that may
have masked the effectiveness of the treatment drink. However,
high habitual polyphenol consumers were likely to have been
captured by the exclusion criterion of .3 portions of fruit and
vegetables/d, and it is unlikely that the habitual diets of the
participants would have varied substantially between the 2 arms
of the study. A strength of our data is its generalizability; effects
were observed regardless of any variability in habitual poly-
phenol intake and in the context of the participants’ normal
diets. Future studies should assess habitual intake with food
diary records together with urinary measures of biomarkers and
metabolites, which also provide evidence of treatment compli-
ance. Finally, in light of the observed carryover effects, re-
searchers should consider incorporating a suitable washout
period before commencing similar polyphenol interventions
(and between arms) to reduce the effects of habitual polyphenol
intake, thus allowing a more sensitive assessment of the in-
tervention. Habitual dietary polyphenol intake before trial
commencement and during the trial could account for some of
the variance indicated by the condition 3 study phase in-
teraction for verbal recall.
In summary, consumption of CGJ for 12 wk was associated
with subtle improvements in immediate spatial memory and safer
driving behavior relative to the placebo in this sample of healthy
working mothers (aged 40–50 y) of preteen children aged.
This is the first study to our knowledge to demonstrate the
benefits of CGJ in healthy adults on domain-specific and ev-
eryday cognitive tasks such as driving. However, it is important
to acknowledge that there were no effects on most cognitive
outcomes; in addition, there was evidence for enduring flavonoid
effects such that when CGJ was consumed during the first arm
some of the associated benefits persisted into the second arm
when the placebo was consumed. Furthermore, practice effects
were observed such that performance was generally better
during the second arm regardless of condition. The combi-
nation of the enduring and practice effects may have masked
some of the potential effects of the CGJ, particularly in this
healthy middle-aged sample in which the effects of nutritional
interventions are likely to be small. These findings have clear
implications for the design of future crossover interven-
tions and indicate that the cognitive effects of CGJ are not
exclusive to older adults and adults with neurodegenerative
disease. Future studies should seek to explore the strength and
length of cognitive effects after the cessation of flavonoid
supplementation.
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